絞り込み

16403

広告

「hepatocellular carcinoma or hepatoma or hcc and wilson disease」の検索結果

110137件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

CISD2 Haploinsufficiency Disrupts Calcium Homeostasis, Causes Nonalcoholic Fatty Liver Disease, and Promotes Hepatocellular Carcinoma.

Splenectomy after partial hepatectomy accelerates liver regeneration in mice by promoting tight junction formation via polarity protein Par 3-aPKC.

Hepatic Falciform Artery Demonstrating MAA Uptake in the Anterior Abdomen Prior to Embolization.

Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.

Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.

Lithospermum Erythrorhizon Root and its Naphthoquinones Repress SREBP1c and Activate PGC1α through AMPKα.

External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study. (HEP-17-0903).

A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection.

AKT-mediated phosphorylation of ATG4B impairs mitochondrial activity and enhances the Warburg effect in hepatocellular carcinoma cells.

Tumor suppressor role of miR-503.

The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients.

Long non-coding RNA XLOC_010235 correlates with poor prognosis and promotes tumorigenesis of hepatocellular carcinoma.

Spontaneous Elimination of Hepatitis C Virus Infection.

Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon.

Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma.

The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma.

Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study.

Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review.

Surrogate endpoint for overall survival in assessment of adjuvant therapies after curative treatment for hepatocellular carcinoma: a re-analysis of meta-analyses of individual patients' data.

Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります